Harvey K

Quantified Citizen, Vancouver, BC, Canada.

4 papers · ORCID

ArticlePsilocybin

A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience.

Back AL, McGregor BA, Thorn LL +13

Europe PMC2026
ArticlePsilocybin

Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic: A Randomized Clinical Trial.

Back AL, Freeman-Young TK, Morgan L +12

Europe PMC2024
ArticlePsilocybin

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

Rootman JM, Kiraga M, Kryskow P +5

Europe PMC2022
ArticlePsilocybin

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

Rootman JM, Kryskow P, Harvey K +6

Europe PMC2021